🇺🇸 FDA
Patent

US 11052060

Compounds and methods for treating autoimmunity

granted A61KA61K31/198A61K31/216

Quick answer

US patent 11052060 (Compounds and methods for treating autoimmunity) held by The Regents of the University of Colorado, a Body Corporate expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/198, A61K31/216, A61K45/06, A61P